AB002. Using Rutherford backscattering spectrometry for in situ characterization of boron neutron capture therapy lithium targets
Acknowledgments
The authors acknowledge all members of the BNCT Laboratory for technical support and their foreign collaborators for providing different lithium target samples.
Footnote
Funding: None.
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://aes.amegroups.com/article/view/10.21037/tro-25-ab002/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study involved only physical experimentation on materials, without the use of human or animal subjects, and thus did not require ethical approval.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
Cite this abstract as: Makarov A, Bikchurina M, Bykov T, Kasatov D, Kolesnikov I, Koshkarev A, Savinov S, Shchudlo I, Sokolova E, Taskaev S. AB002. Using Rutherford backscattering spectrometry for in situ characterization of boron neutron capture therapy lithium targets. Ther Radiol Oncol 2025;9:AB002.

